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Abstract 
Background: Artificial intelligence (AI) research is highly dependent on the nature of the data available. With the 
steady increase of AI applications in the medical field, the demand for quality medical data is increasing significantly. 
We here describe the development of a platform for providing and sharing digital pathology data to AI researchers, 
and highlight challenges to overcome in operating a sustainable platform in conjunction with pathologists.
Methods: Over 3000 pathological slides from five organs (liver, colon, prostate, pancreas and biliary tract, and kidney) 
in histologically confirmed tumor cases by pathology departments at three hospitals were selected for the dataset. 
After digitalizing the slides, tumor areas were annotated and overlaid onto the images by pathologists as the ground 
truth for AI training. To reduce the pathologists’ workload, AI‑assisted annotation was established in collaboration with 
university AI teams.
Results: A web‑based data sharing platform was developed to share massive pathological image data in 2019. This 
platform includes 3100 images, and 5 pre‑processing algorithms for AI researchers to easily load images into their 
learning models.
Discussion: Due to different regulations among countries for privacy protection, when releasing internation‑
ally shared learning platforms, it is considered to be most prudent to obtain consent from patients during data 
acquisition.
Conclusions: Despite limitations encountered during platform development and model training, the present medi‑
cal image sharing platform can steadily fulfill the high demand of AI developers for quality data. This study is expected 
to help other researchers intending to generate similar platforms that are more effective and accessible in the future.
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Background
Artificial intelligence (AI) is considered to offer a collec-
tive intelligence method to solve problems based on data 
that is applicable to all research fields or industries. To 
cope with the COVID-19 pandemic, occurring in 2020, 
governments, public institutions, and private compa-
nies in numerous countries including the United States 
and South Korea, have been encouraging organizations 
and individual researchers to make various attempts at 
Open Access
*Correspondence:  jinchoi@snu.ac.kr
3 Department of Biomedical Engineering, College of Medicine, Seoul 
National University, Seoul, Republic of Korea
Full list of author information is available at the end of the article
Page 2 of 8Kang et al. BMC Med Inform Decis Mak          (2021) 21:114 
improving data sharing, including tracking the patients’ 
routes, and for developing therapeutics [1–4].
In particular, recent medical imaging studies have 
actively used AI approaches [5]. Harvard University 
reported that the use of AI may potentially reduce the 
error rate of a pathologists’ prediction from 3.4% to 0.5% 
when a deep-learning system is combined with patholo-
gist predictions, Wang et  al. [6] In applying a deep-
learning algorithm among patients in the emergency 
department of Seoul National University Hospital vali-
dated the performance of AI approaches in the clinical 
field with respect to improving the diagnostic accuracy 
and the waiting time [7].
AI requires large amounts of data, especially annotated 
data, to yield acceptable outcomes [5, 8–10]. Therefore, 
large-scale information technology companies, includ-
ing Amazon Web Services (AWS), Microsoft, and Google 
have recently released public COVID-19-related datasets 
such as the “AWS COVID-19 data lake” and “COVID-19 
Open Research Dataset”[11–13]. To promote advance-
ments in AI approaches, it is necessary to collect curated 
and annotated data as learning material; however, data 
collection for AI training is not a simple task, especially 
for medical imaging.
The reasons for this challenges are as follows. First, 
medical images can be of a relatively large size. For exam-
ple, the size of digital pathological images from a tissue 
specimen is in the gigapixel range, and contains over a 
million cells, nuclei, and other cellular structures [14–17]. 
Considering the characteristics of AI approaches, large 
amounts of data are required; therefore, the entire train-
ing dataset would increase in size [8, 9, 15–18]. Second, 
annotation of collected medical images is labor-intensive, 
time-consuming, and expensive because experts have to 
annotate them manually [8, 15, 17–19]. Finally, medical 
images contain a personal information; therefore, it is not 
easy to secure and share medical images while conform-
ing with privacy regulations [8–10].
To address these limitations, the Ministry of Health 
and Welfare of the Republic of Korea has supported stud-
ies to develop and share AI learning materials since 2018; 
we are currently participating in the first phase (2018–
2020) of these studies, and have been carrying them out 
successfully by constructing a data sharing platform, 
termed the Pathology Artificial Intelligence Platform 
(PAIP). Over 1700 digital pathological images have been 
provided as the AI learning dataset on the PAIP to date, 
and every image includes a high-quality annotation of the 
tumor area implemented by expert pathologists. Moreo-
ver, we organized a pathology AI challenge as a part of 
the MICCAI 2019 Grand Challenge [20], which has 
inspired other researchers to conduct subsequent related 
studies [21, 22]. Before proceeding to the second phase 
of the project, we here provide a retrospective review on 
our experiences and challenges faced during data collec-
tion, describe the construction of the platform over the 
past 2 years, and share the implications of our previous 
studies testing this platform. This experience can pro-
vide guidance for future developments to improve the 




Pathological slides for PAIP were selected from resected 
tissue and biopsy tissue slides acquired by the Depart-
ment of Pathology at Seoul National University Hospital, 
Seoul National University Bundang Hospital, and SMG-
SNU Boramae Medical Center from 2005 to June 2018. 
To obtain high-quality data in accordance with ethical 
standards, the following main principles were premised 
from the selection stage. First, we targeted histologically 
confirmed tumor cases in five organs (the liver, colon, 
prostate, pancreas and biliary tract, and kidney). Patholo-
gists personally selected all of the slides, including at least 
30% of tumor and normal tissues. Second, for cases of 
human-derived materials obtained after February 2013, 
the patients’ consent to donate specimens was required 
in accordance with the Enforcement Rule of the Bio-
ethics and Safety Act [23]. Third, cases of dead patients 
were also included. To confirm the patient’s deaths, 
we only used the patient’s resident registration num-
ber, which was not collected by the researchers directly. 
Patient deaths were also confirmed through a third party, 
the Bureau of Medical Information Protection at Seoul 
National University Hospital. Cases with insufficient clin-
ical or pathological information required for AI learning 
and cases without donation consent since February 2013, 
were excluded from the data.
Carcinoma samples of the five major organs were 
selected among numerous target organs, as their diag-
nosis rate has displayed an increasing tendency in Korea. 
Furthermore, some morphologically similar carcinomas 
were selected from other organs, considering metas-
tases. For histologically identical carcinomas, images 
were selected with maximally different morphologies. 
These selection criteria would help AI models to learn 
from our data and thus expand their applications for 
diagnosing cancers originating from other organs. The 
selected histological types of carcinomas were adenocar-
cinoma, hepatocellular carcinoma, and renal cell carci-
noma. Of the total 3100 slides, 400–900 slides from each 
organ, were finally selected for the AI learning materials 
(Table 1).
The selected slides were stained using hematoxylin 
and eosin or through immunohistochemistry (IHC), 
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and a high-quality slide scanner (Leica Aperio AT2) was 
used to produce a 20 × whole slide image (WSI) in the 
SVS file format. The scanner can simultaneously pro-
cess up to 400 slides, and the time required depends on 
the size of the sample tissue. The process took approxi-
mately 8–10  h in each case. All WSIs generated were 
stored in a large-capacity server after de-identifying the 
patient data.
De‑identification
The curated data were anonymized at the Department 
of Pathology, Seoul National University Hospital, except 
for the information disclosed on the data-sharing plat-
form (organ, histological diagnosis, differentiation, 
and pathological information). The pathological label 
assigned to every slide, and the micro-image including 
that label, were deleted from the WSI file, and the file 
name was replaced with a temporary research num-
ber. Finally, when transferring the data to the learn-
ing platform server, the research number was deleted, 
and the file name of the WSI was randomly assigned 
in accordance with the file nomenclature (Fig. 1) based 
on the Guidelines for De-identification of Personal 
Data of the Republic of Korea (Ministry of Interior and 
related ministries, 2016) [24]. Several precautions were 
followed to ensure that any information potentially 
identifying subjects, including the patients, was not 
contained in the collected dataset.
Annotation
De-identified WSIs were directly annotated by one of six 
pathologists from Seoul National University Hospital, 
Seoul National University Bundang Hospital, and SMG-
SNU Boramae Medical Center. One pathologist from 
Boramae Hospital annotated 400 kidney cancer images, 
while the annotation of 900 colon cancer cases was car-
ried out by three pathologists from Seoul National Uni-
versity Hospital. The pathologists used an annotation 
tool (Aperio) to mark tumor areas and diagnostic infor-
mation in an XML file format. Thereafter, other patholo-
gists implemented a crosscheck to secure the reliability 
of the annotation. These annotations were of sufficiently 
high intensity to complete the process for approximately 
one slide per day on average when the pathologists per-
formed their clinical tasks in parallel, and it is worth not-
ing that the annotated slide images were considered to 
provide very valuable data.
A sample of an annotated WSI is shown in Fig. 2. All 
WSIs were matched with SVS and XML files at 1:1 pair-
ing, and the annotation layers in the XML file of each 
cancer type were standardized, helping developers to 
identify and train medical images upon first handling. An 
example of tumor annotation in an XML file is as follows. 
First, the closed boundary was marked in units of the 
variable tumor. Second, the normal area inside the viable 
tumor was separated using the negative pen tool (Nega-
tiveROA = “1”). Furthermore, typical normal cells outside 
the viable tumor were marked as the non-tumor area, 
which was designed to provide developers with abun-
dant training material. The XML thus generated could be 
overlaid on the SVS file through the viewer to intuitively 
assess the tumor area, as shown in Fig. 2.
However, after manual annotation of 900 cases of 
colorectal cancer, manual slide annotation became 
Table 1 Number of images acquired by cancer type
Organs Histology Number 
of 
images
Liver Hepatocellular carcinoma 600
Colon Adenocarcinoma 900
Prostate Adenocarcinoma 600
Pancreas and biliary 
tract
Adenocarcinoma 600
Kidney Renal cell carcinoma 400
Total 3100
Fig. 1 File nomenclature for whole slide image files Fig. 2 Annotated whole slide image sample
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challenging owing to the complexity of the boundary of 
the lesions and the large amount of data required for AI 
learning. Accordingly, as of 2019, an AI-assisted anno-
tation process was newly established in collaboration 
with Korea University and Seoul National University AI 
team (Fig.  3). During the AI-assisted annotation pro-
cess, annotation was first guided by AI, and the pathol-
ogist subsequently examined and corrected the results 
to confirm the final annotation. This process improved 
the workload, along with the productivity of the pathol-
ogist and the annotation accuracy because it was 
advantageous for precisely marking the lesion bound-
ary (Fig.  4). The process was first applied for annotat-
ing 300 hepatocellular carcinomas after verifying its 
validity with the PAIP2019 challenge dataset, and was 
then continuously applied for annotating other organs. 
Gradually, few manual annotations were able to gather 
the targeted large size of the dataset (Table 2).
Utility and discussion
Web‑based open platform construction and data sharing
To provide high-quality slides for AI-based learning, 
we developed a web-based open platform, termed PAIP 
(http:// wisep aip. org), in collaboration with Prompt 
Fig. 3 Artificial intelligence‑assisted annotation process
Fig. 4 Enhancement by artificial intelligence‑assisted annotation process
Table 2 Status of manual annotation





Colon 900 900 (100%) 0 (−)
Liver 600 300 (50%) 300 (50%)
Prostate 600 310 (52%) 290 (48%)
Kidney 400 103 (26%) 297 (74%)
Pancreas and biliary 
track
600 10 (2%) 590 (98%)
Total 3100 1623 (52%) 1477 (48%)
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Technology Ltd. PAIP was developed using Ruby on 
Rails, and the MARIA database was selected for the 
operation. Considering the open access and scaling issue 
of large data, we implemented PAIP on AWS EC2 RDS. 
In total, 1781 digital images of > 1.3 TB in size have been 
released through the platform thus far.
All slides released in PAIP were provided as a single set 
of SVS and XML files, and were accessible to all research-
ers. Furthermore, after submitting the consent forms for 
the use of data (“data use agreement”, DUA), researchers 
receiving approval could download the data required, and 
were free to use it as deemed necessary except for com-
mercial purposes under the Creative Commons License 
(CC BY-NC 4.0). However, to prevent reckless data leak-
age and use, users were managed at four levels based on 
their right to use the data. Permissions according to user 
level are shown in Table 3.
Furthermore, L2 users (DUA-approved) were requested 
to submit an annual report to regularly manage user 
rights and follow the status of data usage, thus facilitating 
renewal L2 users to access the data continuously for a 
certain period.
PAIP includes some visual functions to activate data 
utilization and enhance user convenience, while manag-
ing the user rights. All data include file names in accord-
ance with standardized nomenclature, allowing users to 
select and download only the characteristics of the data 
that they selected with the diagnostic information filters 
provided by the platform. For example, if users wanted 
to download only IHC-stained data among colon cancer 
images with the adenocarcinoma histological type, they 
only needed to click the corresponding checkbox in the 
filter area. Each of the data files were arranged in the 
thumbnail layout, allowing users to intuitively browse 
and select the medical image data, and the administrator 
could systematically and conveniently manage the slide 
images (Fig. 5).
Moreover, five common pre-processing algorithms for 
AI modeling learners were provided on the platform. 
These algorithms made it easy to load and match massive 
images into the deep learning model at the preliminary 
stage. For example, one algorithm could divide the WSI 
into standardized patches or could connect the predic-
tion results of the patch units to WSI units. Table 4 pro-
vides a list of the pre-processing algorithms used for this 
purpose.
Organization of the AI challenge
Based on the data-sharing platform established in 
this study, the international pathology AI challenge, 
PAIP2019 (https:// paip2 019. grand- chall enge. org) was 
held in conjunction with MICCAI, which was deemed 
the “AI World Cup” of the medical community. The 
Table 3 User level management
User level Right to use









○ ○ ○ ○
L3 (Membership) ○ ○ ○ ○
Fig. 5 Screenshot of the pathology artificial intelligence platform and the thumbnail view
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challenge was conducted for about 6  months with the 
theme of liver segmentation, and provided 100 WSIs of 
liver hepatocellular carcinoma from PAIP as training and 
test datasets. In total, 28 teams from 12 countries partici-
pated in the challenge, and participants could develop AI 
models using PAIP data.
Results
Since 2018, we have been participating in government-led 
research projects to construct an open platform for AI 
learning, and have curated 3100 images by digitally imag-
ing the pathological slides of 5 organ carcinomas to date. 
The data included de-identified patient information, fun-
damentally blocked through multiple stages of de-identi-
fication, along with annotations from skilled pathologists. 
The dataset thus curated was released sequentially on 
PAIP and will be released toward the end of 2020. Fur-
thermore, this platform is based on the concept of the 
dataset provider, suggesting methods to standardize and 
refine pathological images with high-quality annotations 
for AI researchers, rendering it an intuitive platform for 
developers without medical knowledge to easily identify 
diagnostic data contained in the dataset.
Principal findings
At the initial data collection stage, data collection proved 
to be difficult owing to protective regulations for patient 
information. In particular, South Korea Personal Infor-
mation Protection Act is quite comprehensive; there-
fore, it was difficult to completely eliminate the risk of 
invading patient privacy. Further, after two consultations 
with a law firm, it became clear that the responsibilities 
to conform with this Act could not be avoided. Hence, it 
was difficult and time-consuming to conduct these stud-
ies with high confidence. Fortunately, in January 2020, 
some of these risks were resolved as amendments of 
three major data privacy laws (Personal Information Pro-
tection Act, Act on the Promotion of the Use of the Infor-
mation Network and Information Protection, and Credit 
Information Use and Protection Act) were passed by the 
National Assembly of the Republic of Korea. Owing to 
different regulations among countries, when releasing 
internationally shared learning platforms, including this 
PAIP, it seems ideal to receive consent from patients at a 
preliminary stage.
In fact, pathologists did not have sufficient time to 
work in the field and faced numerous difficulties in gen-
erating the database of these high-quality data along 
with managing their clinical practice. The colon and liver 
cancer annotation, which was carried out in the early 
stages, was particularly challenging because patholo-
gists curated > 1000 whole slides manually. Such tumors 
required different annotation levels depending on the 
characteristics of the carcinoma. Therefore, after 100% 
of the colorectal cancer data were manually annotated, 
the liver cancer annotation was jointly implemented by 
the AI team of the university. When the AI team first dis-
cerned the tumor area, pathologists could save time by 
correcting and confirming the annotation, thus increas-
ing their efficiency. This effect is expected to be maxi-
mized with improvements in AI approaches. Even when 
applying AI approaches, pathologists still manually draw 
slides for training and facilitating learning by AI models. 
Such efforts and time are required to modify and pro-
vide feedback on the results of AI-based approaches, 
and marked improvements in working efficiency are now 
expected. Therefore, our future studies are aimed at shar-
ing more diverse pathological images using this platform.
Finally, it is important to systematically set the file 
names for files containing diagnostic information for the 
effective accumulation and utilization of large amounts of 
data. In addition, it is recommended to secure adequate 
slots in advance in case additional diagnostic informa-
tion (e.g., perineural invasions are to be added in the 
future) or considering scalability for linking with other 
platforms.
Limitations
For the annotation phase we tried AI-assisted annota-
tion, which is joint work with pathologists, but we did 
not noticeably reduce the workload of the pathologists. 
We trained AI models for five organs. Each model had to 
go through at least one more feedback cycle to achieve 
the desired outcome. The accuracy of each AI model var-
ied depending on the cancer. We measured the accuracy 
of the AI annotation models using mIoU (mean Intersec-
tion over Union). This indicator shows how accurately AI 
algorithm can make a prediction compared to the ground 
truth given by pathologists. For the liver cancer model, 
the mIoU was 0.62 in the first round. When pathologists 
corrected the annotation of AI, the accuracy increased to 
0.83. For prostate cancer and kidney cancer the accuracy 
of AI was 0.86 and 0.80 respectively. In the case of pan-
creatic cancer, the accuracy of AI annotation dropped to 
Table 4 List of five pre‑processing algorithms
Toolbox no Major function
Toolbox #1 Generating and classifying patches
Toolbox #2 Smooth stitching of prediction patches
Toolbox #3 Generating heat map and overlay 
pyramid zoom image
Toolbox #4 SVS load and tissue mask segmentation
Toolbox #5 XML load and convert to masks
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0.66. The low accuracy appeared to come mainly came 
from the gland level annotation.
The server of the data-sharing platform was used by 
selecting the AWS. Although the AWS has the advantage 
of transferring large files owing to a wide bandwidth and 
paying as much as the capacity used, it has the typical 
feature of increased cost with increasing data accumu-
lation and usage. Initially, the PAIP cost approximately 
USD 100; however, by 2020, more than USD 1000 was 
being spent monthly on the AWS. Therefore, the cost of 
using a cloud server was considered to be an economic 
burden. Thus, in the second stage, transition to a local 
server will be considered.
Conclusions
This study describes the construction of a web-based 
medical AI data-sharing platform, through which we 
could reveal a high-quality pathology dataset annotated 
by pathologists. To this end, three hospitals collaborated 
to collect the data, who worked closely with university AI 
teams and a private solutions company to resolve vari-
ous issues and to systematically manage massive medical 
image data. Thus, the constructed database offers a valu-
able research resource for AI researchers and for others. 
We intend to continue this effort and hope that our expe-
rience will help other researchers who wish to construct 
such platforms in the future.
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